Translational Genomics Research Institute

Translational Genomics Research Institute
Type	Research Institute
Industry	Genomics
Founded	July 2002, Phoenix, Arizona, United States
Headquarters	Phoenix, Arizona, United States
Key people	Jeffrey Trent
Revenue	$51.7 million (2007); $18.3 million (2003);
Number of employees	258 (2008)
Website	www.tgen.org

Short description: Research institute

A non-profit genomics research institute.

[ ⚑ ] 33°27′10.68″N 112°4′1.83″W / 33.4529667°N 112.067175°W / 33.4529667; -112.067175

The Translational Genomics Research Institute at night

The Translational Genomics Research Institute (TGen)

is a non-profit genomics research institute based in Phoenix, Arizona, United States.

History and activities

TGen was established in July 2002 by Jeffrey Trent in Phoenix, Arizona, with an initial investment of US$100 million from Arizona public and private-sector investors.^[1]

The field of translational genomics research searches for ways to apply results from the Human Genome Project to the development of improved diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes and other complex diseases.

The mission of TGen is to make and translate genomic discoveries into advances in human health.^[2] TGen has contributed to the growth of scientific research and biotechnology in Arizona. The institute has been involved in collaborations and studies, such as the research on chronic traumatic encephalopathy (CTE) in former NFL players in partnership with Exosome Sciences.

TGen Administration

Jeffrey M. Trent, Ph.D., President & Scientific Director^[1]
Sunil Sharma, MD FACP, Deputy Director
Michael Bassoff, President, TGen Foundation
Daniel Von Hoff, M.D., F.A.C.P., Executive Vice President, Physician-in-Chief^[2]
Tess Burleson, MBA, CPA, Chief Operating Officer and President, TGen Accelerators
Chuck Coleson, Chief Financial Officer
Galen Perry, Vice President, Marketing and Communications
Brady Young, Vice President, Human Resources
Kendall Van Keuren-Jensen, co-Director^[3]

References

↑ ^1.0 ^1.1 ^1.2 ^1.3 ^1.4 Alltucker, Ken (16 April 2008). "5-year-old TGen fights for funding". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416.html.
↑ ^2.0 ^2.1 Alltucker, Ken (16 April 2008). "Cancer-drug trials show promise". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416side.html.
↑ "Exosome Sciences, TGen to Launch Study of CTE in Former NFL Players". CellOMICs. 26 March 2018. https://www.clinicalomics.com/articles/exosome-diagnostics-tgen-to-launch-study-of-cte-in-former-nfl-players/1551.

External links

Official website

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Translational Genomics Research Institute. Read more

[Alltucker20080416-1] 1.0 ^1.1 ^1.2 ^1.3 ^1.4 Alltucker, Ken (16 April 2008). "5-year-old TGen fights for funding". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416.html.

[:0-2] 2.0 ^2.1 Alltucker, Ken (16 April 2008). "Cancer-drug trials show promise". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416side.html.

[3] "Exosome Sciences, TGen to Launch Study of CTE in Former NFL Players". CellOMICs. 26 March 2018. https://www.clinicalomics.com/articles/exosome-diagnostics-tgen-to-launch-study-of-cte-in-former-nfl-players/1551.